Literature DB >> 17581165

Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit.

Valérie Porra1, Janine Bernaud, Pierre Gueret, Pascaline Bricca, Dominique Rigal, Gilles Follea, Dominique Blanchard.   

Abstract

BACKGROUND: As an alternative to the cumbersome Kleihauer-Betke test (KBT), flow cytometry represents a powerful method for the identification and quantification of fetal red blood cells (RBCs) in maternal circulation. STUDY DESIGN AND METHODS: The aim of this study was to evaluate the Fetal Cell Count kit (IQ Products), an innovative flow cytometric method, based on the combination of antibodies directed, respectively, against fetal hemoglobin (HbF) and carbonic anhydrase (CA), a marker expressed after birth, to discriminate fetal RBCs from adult F cells containing HbF. The investigation was performed by two French laboratories that compared the data obtained by flow cytometry and KBT in 455 pregnant or just-delivered women as well as in 124 artificial mixtures containing from 0.01 to 5.00 percent cord cells.
RESULTS: The FL1/FL2 histogram allowed distinction between fetal RBCs (HbF+, CA-), F cells (HbF+, CA+), and adult RBCs (HbF-, CA+). The limits of detection and quantification were determined at 0.03 and 0.10 percent or 0.02 and 0.05 percent when analyzing 100,000 or 200,000 events, respectively. Linearity was demonstrated between 0.01 and 5.00 percent fetal cells in the mixtures (r = 0.95, p < 0.01). A good correlation between fluorescence-activated cell sorting (FACS) and KBT results was obtained with artificial mixtures (r = 0.94, p < 0.01). From the 405 Kleihauer-negative samples, none were identified as positive by FACS. Among the 50 Kleihauer-positive samples, 6 were shown not to contain fetal cells but F cells by FACS.
CONCLUSION: With this new dual-color flow cytometric method, accurate evaluation of fetomaternal hemorrhage was achieved even in the face of HbF of maternal origin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581165     DOI: 10.1111/j.1537-2995.2007.01271.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Expression of pituitary tumor-transforming 2 in human glioblastoma cell lines and its role in glioblastoma tumorigenesis.

Authors:  Yunbao Guo; Yimeng Shao; Jing Chen; Songbai Xu; Xingdong Zhang; Haiyan Liu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

2.  Experience in the evaluation of foeto-maternal haemorrhage by flow cytometry.

Authors:  Pier Luigi Tazzari; Francesca Ricci; Silvia Manfroi; Pasqualepaolo Pagliaro
Journal:  Blood Transfus       Date:  2012-10-10       Impact factor: 3.443

3.  Mild-to-moderate foeto-maternal haemorrhage in the third trimester and at term of pregnancy: quantitative determination and clinical-diagnostic evaluation.

Authors:  Fausta Beneventi; Chiara Cavagnoli; Elena Locatelli; Silvia Bariselli; Margherita Simonetta; Gianluca Viarengo; Cesare Perotti; Arsenio Spinillo
Journal:  Blood Transfus       Date:  2017-04-19       Impact factor: 3.443

4.  The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization.

Authors:  Sarah Horvath; Patricia Tsao; Zhen-Yu Huang; Ling Zhao; Yangzhu Du; Mary D Sammel; Eline T Luning Prak; Courtney A Schreiber
Journal:  Contraception       Date:  2020-03-03       Impact factor: 3.375

Review 5.  Heterogeneity of fetal hemoglobin production in adult red blood cells.

Authors:  Eugene Khandros; Gerd A Blobel
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.